Retroperitoneal Tumors

Stanley Bruce Malkowicz, MD




Retroperitoneal tumors are relatively rare lesions yet of interest to the urologist because they present in a key anatomic location and often involve urologic organs. Because of their location these lesions usually demonstrate indolent growth and present as relatively large lesions. Although some lesions are benign the majority are malignant and are best treated by surgical extirpation when possible. This often requires the excision of involved organs, most often the kidney. Beyond the obvious effort to obtain negative surgical margins during removal, optimal treatment strategies are difficult to systematize owing to the inability to accrue sufficient prospective evidenced-based data. Additionally, much of the available data is intertwined with surveys and treatment approaches to sarcomas of extremities.


The clinical approach to these lesions from the perspective of assessment and surgery is fairly standard. Anthracycline chemotherapy is the basis of treatment, and the advantages and limitations of this approach have been further defined by recent treatment series. The exact role and efficacy for radiation therapy in these lesions continues to be explored. The role for targeted therapy is being investigated.



Incidence and Etiology


Retroperitoneal sarcomas are relatively rare lesions that comprise nearly 15% of the soft tissue sarcomas that occur annually and thus account for approximately 2000 cases per year (Jemal, 2009). Surveillance, Epidemiology, and End Results (SEER) data from the U.S. National Cancer Institute have identified 2.7 cases per 100,000 individuals at a steady rate over the past 30 years (Porter, 2006). Actually, fewer than half of all retroperitoneal tumors are sarcomas. Fifteen to 20 percent are benign lesions such as lipomas, and the remainder consist of primary lymphoma or primary urologic tumors such as germ cell lesions (Jemal et al, 2002). Presentation is usually in the sixth decade of life, but the age range is broad (Gronchi et al, 2009). There is a slight male predominance, and two thirds of patients have high-grade malignancy. Approximately 10% will present with metastatic disease, with lung and liver the most common sites of spread (Lewis, 1998).


Although histologic types may span any age range, rhabdomyosarcoma tends to cluster in younger patients, even excluding the pediatric population, whereas malignant fibrous histiocytoma is seen in older patients. Gastrointestinal stromal tumor has been more thoroughly recognized recently, and appropriate characterization is key because targeted therapeutic approaches are available for this lesion.


The etiology of retroperitoneal sarcoma is poorly understood. The etiology of sarcoma has been attributed to prior radiation exposure and toxins, yet it is difficult to account for this in the majority of cases. Approximately 0.1% of patients who receive radiation therapy may develop a sarcoma at the treatment site. The most common lesion associated with radiation is malignant fibrous histiocytoma. Some association exists between dioxin exposure and the development of sarcoma, but prolonged periods of exposure and significant latency were also noted (Hardell and Sandstom, 1979).



Pathology


Retroperitoneal sarcomas arise primarily from soft tissues of fibrous and adipose origin as well as muscle, nerve, and lymphatic tissue. These tissues are derived from primitive mesenchyme from the mesoderm with some contribution from neuroectoderm (Economou, 1987). Their location allows for a rather long indolent preclinical course during which time the tumor can grow to significant proportions. This growth may result in local areas of necrosis or liquefaction as the tumor outstrips its vascular supply.


In classic reviews of these lesions the common tissue distribution in descending order is liposarcoma, leiomyosarcoma, and fibrosarcoma, followed by other histologies (McGrath et al, 1984; Karakousis et al, 1985, Jacques et al, 1990; Storm and Mahvi, 1991; Rossi et al, 1993). Malignant fibrous histiocytoma is expressed more prominently in contemporary series; however, owing to intensive pathologic interest in defining this disorder, many tumors previously described as variants of fibrosarcoma or liposarcoma have been reclassified as malignant fibrous histiocytoma (Rööser et al, 1991; Pezzi et al, 1992). Therefore fibrosarcoma has been replaced in frequency order by this condition.


Additionally, several previously characterized leiomyosarcomas are now correctly identified as gastrointestinal stromal tumors. By various histologic and immunohistochemical stratification it became apparent that these tumors were less like smooth muscle and more similar to cells of the myenteric nervous system. It is now believed that these tumors probably originate from stem cells that differentiate toward an interstitial cell of Cajal phenotype (Table 52–1) (Quek and George, 2009).


Table 52–1 Tumors of the Retroperitoneum











Benign





Malignant








The molecular pathology of sarcomas is complex, and many lesions demonstrate the theme of specific chromosomal translocations creating a fusion chimeric transcription factor. A sophisticated understanding of these changes has been further developed in lesions less commonly seen in the adult retroperitoneum. A partial list of these alterations is presented in Table 52–2. These factors interact with the upstream regulatory component of a gene and can significantly affect the expression of that gene at the messenger RNA level. The nucleic acid binding domain of the chimeric transcription factor confers target specificity within the tissue genome while the transcription factor portion of this novel protein determines the transactivation potential and expression level of the target gene (Crozat et al, 1993; Ladanyi, 1995; Panagopoulos et al, 1996; Tschoep et al, 2007; Torsten and West, 2010). The description of this pathologic mechanism predated a similar finding recently described in prostate cancer.


Table 52–2 Genetic Alterations in Retroperitoneal Tumors






























TUMOR ABERRATION GENE(S) INVOLVED
Alveolar rhabdomyosarcoma t(2;13) (q35;q14) PAX3-FKHR
t(1;13) (p36;q14) PAX7-FKHR
Myxoid/round cell liposarcoma t(12;16) (q13;p11) TLS-CHOP
Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLPS) Supernumerary ring chromosomes; giant marker chromosomes Amplification of region 12q14-15, Including MDM2, CDK4, HMGA2, SAS, GL1
Dedifferentiated liposarcoma Same as for ALT/WDLPS Same as for ALT/WDLPS
Sporadic gastrointestinal stromal tumor Activating kinase mutations KIT or PDGFRA

Additionally, the development of extra abnormal chromosomes (ring chromosomes and giant rods) involving chromosome 12 can result in the amplification of certain gene products such as MDM2 and SAS. MDM2 can be involved in TP53 inactivation, which can contribute to carcinogenesis (Berner et al, 1996; Elkahloun et al, 1996). Series of investigations regarding soft tissue leiomyosarcoma have revealed exceptionally complex, multiple gene alterations that are not easily categorized. These molecular insights into the pathology of sarcoma have not translated into therapeutic targets as readily as the gastrointestinal stromal tumors histology but may provide approaches for future therapeutic strategies directed at these lesions (Van Roggen and Hogendoorn, 2000; Nielson and West, 2010).


Gastrointestinal stromal tumors demonstrate activated c-KIT mutations in 8% to 88% of lesions. Additionally, analogous gain of function mutations were demonstrated in platelet-derived growth factor receptor-α (PDGFR-α). These mutations suggested a role for targeted therapy in these lesions (Heinrich et al, 2003; Corless et al, 2004).


Gene expression profiling has also been explored in sarcomas, which allows the identification of some putative biomarkers in the study of these lesions and has suggested that malignant fibrous histiocytoma, rather than a separate entity, may represent a common end point of several different sarcomas (Tschoep, 2010).



Benign Lesions



Lipomas


Lipomas consist almost entirely of mature fat and are uncommonly found in the retroperitoneum. They are probably the most common soft tissue tumor in humans. Most of these lesions occur superficially, but they may occur in other areas, such as the retroperitoneum. Deep lipomas within the retroperitoneum are usually not as well circumscribed as their superficial counterparts and can conform to irregular spaces in this body space (DeWeerd and Dockerty, 1952; Mowat and Clark, 1961). The adipocytes are normal or slightly larger in appearance and have a well-developed vascular network. There is very little in the way of nuclear irregularity. Differing levels of fibrous connective tissue can be found in these lesions. The rim of the lipocyte is reactive for S-100 protein. Although the majority of these masses are idiopathic, they can occasionally be a manifestation of steroid lipomatosis.


Pelvic lipomatosis, although not a distinct tumor per se, was first described in 1959 as an overgrowth of fat in the perivesical and perirectal area. It is a hyperplastic rather a neoplastic entity that can create a space-occupying lesion. Approximately two thirds of patients are African-American, and women are rarely affected (Heyns, 1991). The growth is diffuse rather than nodular, and often it is difficult to distinguish it from normal adipose tissue. The condition may be associated with cystitis glandularis (Yalla et al, 1975). The general clinical course is slowly progressive and may result in the need for urinary diversion (Klein et al, 1988). Occasionally, fat necrosis in these lesions can be mistaken for sarcomatous degeneration (Andac et al, 2003).



Myelolipoma


Myelolipoma is a tumor-like growth of mature fat and bone marrow elements. Although it usually occurs in the adrenal gland it can be seen as an isolated pelvic lesion (Chen et al, 1982; Sanders et al, 1995). It is distinct from extramedullary hematopoietic tumors, which are usually multiple and generally associated with mild proliferative diseases and skeletal disorders. These generally occur in patients older than age 40 years and are rarely greater than 5 cm (Fowler et al, 1992; Mukherjee et al, 2010). They are usually noted as incidental findings on imaging. The adrenal gland can create inferior renal displacement due to a radiolucent mass. Pathologically it may display the features of a lipoma or have a darker appearance if myeloid elements predominate. Adrenal myolipoma development may be secondary to prolonged stress and excessive stimulation with adrenocorticotropic hormone.




Malignant Lesions



Liposarcoma


Liposarcomas are among the most common of primary retroperitoneal tumors and are distinguished by their often large dimensions and range of subtypes. These lesions have their peak incidence between ages 40 and 60 (Kindblom et al, 1975). They account for 10% to 15% of sarcomas, and approximately 20% of these lesions arise in the retroperitoneum. One unfortunate clinical feature of these lesions is their usual tendency to recur, often within the first 6 months after surgery. The principal tissue type is usually recapitulated at the time of recurrence. The rate of metastasis depends on the degree of tumor differentiation, with nearly 90% of poorly differentiated tumors metastasizing (Enterline et al, 1960; Spittle et al, 1971; Weiss and Rao, 1992).


Significant advances in cytogenetics have allowed the reclassification of these lesions on a molecular basis. Well-differentiated and dedifferentiated lesions are a continuum of lesions based on the genetic abnormality of giant and ring chromosomes usually involving chromosome 12. Gene amplification, particularly of MDM2, drives their pathology (Pilotti et al, 1998; Forus et al, 2001). Myxoid and round cell lesions (poorly differentiated myxoid) are another continuum that have fusion transcripts caused by translocations in chromosomes 16 and 12 as their principal pathologic feature. Pleomorphic liposarcomas are rare and poorly understood (Dal Cin et al, 1997).


Unlike benign lipomas, liposarcomas may bear little resemblance to classic fat-filled structures. The gross lesion is usually described as having a “fish flesh” appearance and, although generally encapsulated, it can often display invasive characteristics. Besides the retroperitoneum, these lesions arise in the deep soft tissues of the proximal extremities. They generally present as very large lesions when originating from the retroperitoneum.


Myxoid liposarcomas are the most common type and usually occur in the lower extremity. They account for 50% of sarcomas and represent a large proportion of retroperitoneal lesions. The peak presentation is in the fifth decade. These tumors display a background of stellate mesenchymal cells and a prominent capillary pattern often described as a “chicken wire” appearance. The distinct cell is the lipoblast, which is similar to the fetal adipocyte. These cells are noted by a lipid vacuole that scallops the nucleus. This creates the lipoma-like appearance of these lesions, which can demonstrate fusion proteins (TLS-CHOP) on molecular analysis. Higher-grade lesions tend to demonstrate a higher number of TP53 mutations (Deitos et al, 1997). The round cell subtype is also referred to as a lipoblastic variant and is distinguished by sheets of round cells with lipoblastic differentiation. These lesions are considered the most aggressive part of the spectrum of myxoid lesions.


Well-differentiated liposarcomas most resemble lipomas and are usually designated as low grade. They are a common sarcoma of later life. Subvariants include the lipoma-like, inflammatory, sclerosing, and differentiated types. The first three variants are often confused with benign processes such as scarring or inflammation, whereas the differentiated subtype is often noted in long-standing retroperitoneal lesions and considered higher grade. Generally these lesions are now considered as a group with dedifferentiated lesions because they share genetic similarities.


Pleomorphic liposarcomas comprise 10% to 15% of liposarcomas and are defined as high-grade malignant variants with very bizarre nuclei and huge lipoblasts.



Leiomyosarcoma


Leiomyosarcomas account for less than 10% of all soft tissue sarcomas yet a significant percentage of retroperitoneal sarcomas because almost half of them appear in this region. They have a 2 : 1 female-to-male presentation and generally occur in middle age (mean age 60 years). The molecular pathology of these lesions has not been reduced to any common pathway and demonstrates a tremendous amount of variation on cytogenetic and molecular analysis. The tumors are usually categorized by site of origin (soft tissue, vascular, or superficial), although many of the soft tissue lesions are believed to originate from smaller blood vessels. On imaging examinations, however, they appear to have moderate to low vascularization.


Grossly, low-grade leiomyosarcomas can be difficult to distinguish from leiomyomas but higher-grade lesions display a more infiltrative fleshlike appearance (Shmookler and Lauer, 1983). Low-grade lesions are often distinguished from leiomyomas by their chromatin pattern and the number of mitoses (more than five mitoses per high-power field) present in the specimen.


Again, a continuum exists in the pathologic progression of these smooth muscle lesions; therefore the cut point between benign, moderate, and high grade may sometimes be arbitrary. There is little evidence of sarcomatous degeneration from benign leiomyomas. The characteristic pathologic finding of a leiomyosarcoma is malignant spindle cells with “cigar”-shaped nuclei. The muscle fascicles interweave. These tumors immunohistochemically stain for smooth muscle myosin, vimentin, and actin and less often for desmin. They stain negative for S-100. Ultrastructural features include bundles of thin cytofilaments, which can help distinguish leiomyosarcomas from other lesions.


A rare retroperitoneal variant of these tumors are leiomyosarcomas that originate from the great vessels (Demers et al, 1992). These occur predominantly in women. Tumors of the iliac vessels usually present as lower extremity edema, whereas those of the inferior vena cava can display findings consistent with Budd-Chiari syndrome (Cardell et al, 1971). Resection of these lesions is recommended when anatomically feasible. Survival, however, is usually less than 2 years, and many inferior vena caval tumors are unresectable because of the intrahepatic location of many of these lesions.



Malignant Fibrous Histiocytoma


Malignant fibrous histiocytoma was originally described in 1963 and has come to be the predominant histologic diagnosis for currently reported soft tissue sarcomas (Ozello et al, 1963). It was first defined as a sarcoma of primary histiocytic origin, but it is now believed that it is a lesion derived from fibroblast differentiation. Many pleomorphic variants of fibrosarcoma, liposarcoma, and rhabdomyosarcoma have been reclassified into this category. With the thorough evaluation of a tumor specimen, distinct regions of leiomyosarcoma, liposarcoma, and other soft tissue sarcomas may be identified. In such cases the tumor may be defined by those findings and the mention of an associated malignant fibrous histiocytoma pattern (Weiss, 1982). These lesions are most often seen on the extremities and are less common in the retroperitoneum. Their molecular pathology is unclear. An analysis of these lesions in the retroperitoneum suggests that many of these could be reclassified as a dedifferentiated liposarcoma and that they may represent a common end point for several tissue types (Coindre et al, 2003; Tschoep et al, 2007). Storiform-pleomorphic, myxoid, giant cell, and inflammatory subtypes of malignant fibrous histiocytoma may coexist in a particular lesion.


The storiform-pleomorphic variant has a distinct but not pathognomonic pinwheel pattern caused by the collagen pattern of curling fascicles of cells. It is the most common variant, usually comprising 40% to 60% of most series. Although this pattern may predominate, it may not be present throughout the lesion in question. Areas of collagen or foamy cells may also be encountered. The nuclei tend to be irregular and large with discernible mitosis. The constellation of tissue histology and nuclear irregularities in addition to the inflammatory components differentiate this lesion from benign entities.


Myxoid malignant fibrous histiocytoma comprises 25% of this overall tumor type. It is often difficult to distinguish it from liposarcoma; however, the myxoid subtype has little neutral fat but is rich in mucopolysaccharide residing in intracytoplasmic vacuoles.


Malignant fibrous histiocytoma, giant cell type, is distinguished by large benign-appearing osteoclasts. Multinucleated giant cells and the stroma comprise the malignant components of this lesion. If cartilage or osteoid is detected, these lesions are classified as a soft tissue osteosarcoma, which usually has a poorer prognosis than malignant fibrous histiocytoma.




Rhabdomyosarcoma


Rhabdomyosarcoma comprises a minor percentage of reported retroperitoneal sarcomas yet is a significant lesion in pediatric oncology as well as pediatric tumors associated with the genitourinary system. These lesions are generally classified as embryonal, botryoid, alveolar, or pleomorphic, with a spindle cell subtype more recently described within the embryonal type (Horn and Enterline, 1958; Cavazzana et al, 1992). The pathology of these lesions is associated with chromosomal abnormalities and the fusion transcripts associated with these translocations.


Embryonal rhabdomyosarcoma comprises more than half of all rhabdomyosarcomas and has a large array of anatomic locations, including the genitourinary tract and retroperitoneum. It can range from very well to poorly differentiated lesions and can express the multiple stages of muscle development. Botryoid lesions are an anatomic variant of the embryonal type and generally found in hollow viscera. The spindle cell subtype is noted for its favorable clinical behavior.


Alveolar rhabdomyosarcoma accounts for approximately 20% of all rhabdomyosarcomas and tends to occur more frequently in the extremities. The tumor is arranged in aggregates of round or oval cells that create irregular spaces reminiscent of alveoli. They can be classified into subtypes based on fusion gene transcripts (PAX-FKHR). These tissues may be surrounded by fibrous septa, and areas of necrosis are not uncommon.


Pleomorphic rhabdomyosarcoma comprises 5% of adult rhabdomyosarcomas and generally occurs in older patients. It usually is found in the extremities and is not unlike malignant fibrous histiocytoma in its appearance. The absence of cross striations makes diagnosis difficult. With all rhabdomyosarcomas, immunostaining for desmin, myoglobin, and muscle-specific actin is useful.




Diagnosis


Because of their slow growth and anatomic location, retroperitoneal tumors (usually sarcomas) tend to grow to a large size before they are detected. In one series of soft tissue sarcomas the average size at diagnosis for extremity lesions was 5 cm, whereas retroperitoneal lesions were 16.5 cm (Hueman et al, 2008); thus such lesions can often be enormous by usual pathologic standards. Although the age at presentation is distributed across a large spectrum, the majority of patients are diagnosed with retroperitoneal tumors in the sixth decade of life. Because the progression of symptoms is slow there is usually a lag time of 5 months from initial symptoms to diagnosis. The principal clinical finding is an abdominal mass and abdominal pain (60% to 80%) (McGrath, 1984). Many patients also experience nausea and vomiting and weight loss (20% to 30%). Neurologic findings are noted in 30% of patients (Cohan et al, 1988

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 4, 2016 | Posted by in ABDOMINAL MEDICINE | Comments Off on Retroperitoneal Tumors

Full access? Get Clinical Tree

Get Clinical Tree app for offline access